Recently, some DNA-damaging drugs, such as teniposide, cisplatin, and olaparib (PARP inhibitor), have manifested the capability to activate cGAS-STING signaling in cancer cells, inducing robust antitumor immune responses. Here, STING1 is linked to cancer.